These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2007632)

  • 21. Clostridium difficile brain empyema after prolonged intestinal carriage.
    Gravisse J; Barnaud G; Hanau-Berçot B; Raskine L; Riahi J; Gaillard JL; Sanson-Le-Pors MJ
    J Clin Microbiol; 2003 Jan; 41(1):509-11. PubMed ID: 12517909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of five cultural procedures for isolation of Clostridium difficile from stools.
    Marler LM; Siders JA; Wolters LC; Pettigrew Y; Skitt BL; Allen SD
    J Clin Microbiol; 1992 Feb; 30(2):514-6. PubMed ID: 1537928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile in Food and Animals: A Comprehensive Review.
    Rodriguez C; Taminiau B; Van Broeck J; Delmée M; Daube G
    Adv Exp Med Biol; 2016; 932():65-92. PubMed ID: 27350639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ceftriaxone on emergence of Clostridium difficile.
    Lejko-Zupanc T; Zakelj J; Strle F; Janc M; Pleterski-Rigler D
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2850-1. PubMed ID: 1482159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteria producing antimicrobials against Clostridium difficile isolated from human stool.
    Khattab RA; Ahmed NA; Ragab YM; Rasmy SA
    Anaerobe; 2020 Jun; 63():102206. PubMed ID: 32339663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of gas chromatography to identification of Clostridium difficile].
    Liao Z; Lai D
    Se Pu; 1997 May; 15(3):216-8. PubMed ID: 15739360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gas-liquid chromatography of cellular fatty acids for identification of staphylococci.
    Stoakes L; John MA; Lannigan R; Schieven BC; Ramos M; Harley D; Hussain Z
    J Clin Microbiol; 1994 Aug; 32(8):1908-10. PubMed ID: 7989541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Typing of Clostridium difficile by western immunoblotting with 10 different antisera.
    Kato H; Cavallaro JJ; Kato N; Bartley SL; Killgore GE; Watanabe K; Ueno K
    J Clin Microbiol; 1993 Feb; 31(2):413-5. PubMed ID: 8432828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile.
    Collier MC; Stock F; DeGirolami PC; Samore MH; Cartwright CP
    J Clin Microbiol; 1996 May; 34(5):1153-7. PubMed ID: 8727893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid identification of Clostridium difficile by direct detection of volatile organic acids from primary isolation media.
    Makin T
    J Clin Pathol; 1984 Jun; 37(6):711-2. PubMed ID: 6373841
    [No Abstract]   [Full Text] [Related]  

  • 31. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027.
    Riley TV; Thean S; Hool G; Golledge CL
    Med J Aust; 2009 Jun; 190(12):706-8. PubMed ID: 19527210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved identification of mycobacteria by using the microbial identification system in combination with additional trimethylsulfonium hydroxide pyrolysis.
    Müller K; Schmid EN; Kroppenstedt RM
    J Clin Microbiol; 1998 Sep; 36(9):2477-80. PubMed ID: 9705377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strain-Dependent Inhibition of Clostridioides difficile by Commensal
    Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM
    J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626
    [No Abstract]   [Full Text] [Related]  

  • 34. Hidradenitis suppurativa and risk for development of Clostridium difficile colitis.
    Lyons AB; Kaddurah H; Peacock A; Zubair R; Vellaichamy G; Norwick P; Ramesh M; Jacobsen G; Hamzavi IH
    Int J Dermatol; 2020 Jun; 59(6):e218-e219. PubMed ID: 32010962
    [No Abstract]   [Full Text] [Related]  

  • 35. Healthcare workers' hands and Clostridium difficile spores: making progress?
    Pop-Vicas A; Baier R
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):16-7. PubMed ID: 24334793
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis and diagnosis of clostridium difficile enterocolitis.
    Möllby R; Aronsson B; Nord CE
    Scand J Infect Dis Suppl; 1985; 46():47-56. PubMed ID: 3906856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
    Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism.
    Klaassen CH; van Haren HA; Horrevorts AM
    J Clin Microbiol; 2002 Jan; 40(1):101-4. PubMed ID: 11773100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.
    DiPersio JR; Varga FJ; Conwell DL; Kraft JA; Kozak KJ; Willis DH
    J Clin Microbiol; 1991 Dec; 29(12):2724-30. PubMed ID: 1757540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of a PCR method for detection of the Clostridium difficile toxin B gene in stool specimens.
    Guilbault C; Labbé AC; Poirier L; Busque L; Béliveau C; Laverdière M
    J Clin Microbiol; 2002 Jun; 40(6):2288-90. PubMed ID: 12037113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.